Need for a Cardiogenic Shock Team Collaborative-Promoting a Team-Based Model of Care to Improve Outcomes and Identify Best Practices
Overview
Authors
Affiliations
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve survival over the past few decades. It is a time-sensitive condition that commonly results in cardiovascular complications and multisystem organ failure, necessitating multidisciplinary expertise. Managing patients with cardiogenic shock remains challenging even in well-resourced settings, and an important subgroup of patients may require cardiac replacement therapy. As a result, the idea of leveraging the collective cognitive and procedural proficiencies of multiple providers in a collaborative, team-based approach to care (the "shock team") has been advocated by professional societies and implemented at select high-volume clinical centers. A slowly maturing evidence base has suggested that cardiogenic shock teams may improve patient outcomes. Although several registries exist that are beginning to inform care, particularly around therapeutic strategies of pharmacologic and mechanical circulatory support, none of these are currently focused on the shock team approach, multispecialty partnership, education, or process improvement. We propose the creation of a Cardiogenic Shock Team Collaborative-akin to the successful Pulmonary Embolism Response Team Consortium-with a goal to promote sharing of care protocols, education of stakeholders, and discovery of how process and performance may influence patient outcomes, quality, resource consumption, and costs of care.
Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management.
Sato R, Hasegawa D, Guo S, Nuqali A, Pino Moreno J J Intensive Care. 2025; 13(1):1.
PMID: 39748440 PMC: 11694368. DOI: 10.1186/s40560-024-00770-y.
Vallabhajosyula S, Alasnag M, Boudoulas K, Davidson L, Pyo R, Riley R JACC Adv. 2025; 3(11):101338.
PMID: 39741647 PMC: 11686056. DOI: 10.1016/j.jacadv.2024.101338.
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future Directions.
Jentzer J, Berg D, Chonde M, Dahiya G, Elliott A, Rampersad P JACC Adv. 2024; 4(1):101432.
PMID: 39720581 PMC: 11666941. DOI: 10.1016/j.jacadv.2024.101432.
Yau R, Mitchell R, Afzal A, George T, Siddiqullah S, Bharadwaj A J Soc Cardiovasc Angiogr Interv. 2024; 3(11):102288.
PMID: 39649821 PMC: 11624379. DOI: 10.1016/j.jscai.2024.102288.
Vallabhajosyula S, Sinha S, Kochar A, Pahuja M, Amico Jr F, Kapur N Curr Cardiol Rep. 2024; 26(10):1123-1134.
PMID: 39325244 DOI: 10.1007/s11886-024-02108-4.